AstraZeneca PLC (AZN) — Strategic Asset Allocation Index
AstraZeneca PLC (AZN) has a Strategic Asset Allocation Index of 26.1% as of September 2023. Strategic assets (PP&E of GBX9.70 Billion plus long-term investments of GBX-) total GBX9.70 Billion, measured against net assets of GBX37.22 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
AstraZeneca PLC Strategic Asset Allocation Index (2000–2022)
This chart shows how AstraZeneca PLC's Strategic Asset Allocation Index has evolved across 23 annual periods from 2000 to 2022. As of September 2023, the index stands at 26.1%, representing strategic assets of GBX9.70 Billion against net assets of GBX37.22 Billion GBX. Explore AstraZeneca PLC cash flow conversion to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for AstraZeneca PLC (2000–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for AstraZeneca PLC from 2000 to 2022, covering 23 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see market cap of AstraZeneca PLC.
| Year | SAAI | Strategic Assets (GBX) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 25.5% | GBX9.45 Billion | GBX9.45 Billion | GBX- | GBX37.06 Billion | ▼ -0.4 pp |
| 2021 | 25.9% | GBX10.17 Billion | GBX10.17 Billion | GBX- | GBX39.29 Billion | ▼ -31.1 pp |
| 2020 | 57.0% | GBX8.92 Billion | GBX8.92 Billion | GBX- | GBX15.64 Billion | ▼ -10.4 pp |
| 2019 | 67.5% | GBX9.85 Billion | GBX8.34 Billion | GBX1.51 Billion | GBX14.60 Billion | ▲ +7.7 pp |
| 2018 | 59.8% | GBX8.40 Billion | GBX7.42 Billion | GBX978.00 Million | GBX14.04 Billion | ▲ +7.3 pp |
| 2017 | 52.5% | GBX8.73 Billion | GBX7.62 Billion | GBX1.12 Billion | GBX16.64 Billion | ▲ +6.1 pp |
| 2016 | 46.4% | GBX7.74 Billion | GBX6.85 Billion | GBX891.00 Million | GBX16.67 Billion | ▲ +8.0 pp |
| 2015 | 38.4% | GBX7.08 Billion | GBX6.41 Billion | GBX669.00 Million | GBX18.44 Billion | ▲ +4.1 pp |
| 2014 | 34.3% | GBX6.73 Billion | GBX6.01 Billion | GBX722.00 Million | GBX19.65 Billion | ▲ +9.2 pp |
| 2013 | 25.0% | GBX5.82 Billion | GBX5.82 Billion | GBX- | GBX23.25 Billion | ▼ -0.4 pp |
| 2012 | 25.4% | GBX6.09 Billion | GBX6.09 Billion | GBX- | GBX23.95 Billion | ▼ -2.0 pp |
| 2011 | 27.4% | GBX6.42 Billion | GBX6.42 Billion | GBX- | GBX23.47 Billion | ▼ -2.3 pp |
| 2010 | 29.7% | GBX6.96 Billion | GBX6.96 Billion | GBX- | GBX23.41 Billion | ▼ -5.4 pp |
| 2009 | 35.1% | GBX7.31 Billion | GBX7.31 Billion | GBX- | GBX20.82 Billion | ▼ -8.8 pp |
| 2008 | 43.9% | GBX7.04 Billion | GBX7.04 Billion | GBX- | GBX16.06 Billion | ▼ -11.8 pp |
| 2007 | 55.6% | GBX8.30 Billion | GBX8.30 Billion | GBX- | GBX14.91 Billion | ▲ +7.3 pp |
| 2006 | 48.3% | GBX7.45 Billion | GBX7.45 Billion | GBX- | GBX15.42 Billion | ▼ -2.7 pp |
| 2005 | 51.0% | GBX6.99 Billion | GBX6.99 Billion | GBX- | GBX13.69 Billion | ▼ -4.7 pp |
| 2004 | 55.8% | GBX8.08 Billion | GBX8.08 Billion | GBX- | GBX14.50 Billion | ▼ -1.1 pp |
| 2003 | 56.8% | GBX7.54 Billion | GBX7.54 Billion | GBX- | GBX13.26 Billion | ▼ -1.9 pp |
| 2002 | 58.8% | GBX6.60 Billion | GBX6.60 Billion | GBX- | GBX11.22 Billion | ▲ +2.6 pp |
| 2001 | 56.2% | GBX5.41 Billion | GBX5.41 Billion | GBX- | GBX9.63 Billion | ▲ +4.3 pp |
| 2000 | 51.9% | GBX4.96 Billion | GBX4.96 Billion | GBX- | GBX9.55 Billion | — |